How Does Prevalence of the Chronic Diseases Fuels Growth of the Transplantation Industry?

The transplantation market generates $13,605.9 million revenue, and it is projected to capture $30,117.5 million revenue in 2030, growing at a rate of 9.2% from 2021 to 2030. It is led by the rising incidences of chronic diseases, such as solid tumors, kidney failure, myelodysplastic disorders, plasma cell disorders, along with disorders of the immune system. 

Moreover, immunosuppressive drugs are projected to experience the fastest growth, rising at a rate of 9.6% in the coming future. It is attributed to the growing prevalence of autoimmune disorders, such as multiple sclerosis, alopecia areata, and arthritis, along with the growing incidences of organ failures, more specifically kidney, liver, heart, and lungs. The rising disposable income of the population in emerging nations is also projected to boost the demand for immunosuppressive drugs in the coming future. 

Under the end user segment, hospitals contribute 50% revenue share to the industry, emerging as major centers for tissue and organ transplantation. In addition, the rising advancements in the healthcare infrastructure, along with the presence of a well-defined database of donors and patients requiring transplants fuel the revenue of the hospitals. 

Transplantation centers contribute extensive revenue to the industry, and it is projected to retain their position in the coming years, led by the growing awareness among donors and patients about these centers due to specialty surgeons and staff members for performing procedures. Moreover, the R&D activities performed in these centers, result in advanced transplantation procedures. 

North America captures the 40% share of the transplantation industry. The U.S. leads the region’s industry, led by the massive number of patients requiring organ transplantation for treatment, more specifically for kidneys, liver, pancreas, heart, liver, and lung transplantation. In addition, growing R&D in healthcare increases the success rate of such activities. 

Therefore, the rising prevalence of chronic diseases boosts industry growth, with growing requirements for organ transplantation.